pGBI-140

N/A

Report date: 2024/09/19 15:13:42

Base Information

Drug NamepGBI-140
Drug Alias NamePbi-shRNA EWS/FLI1 Type 1 LPXPbi-shRNA EWS/FLI1 lipoplexpGBI-140
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionRNA interferenceEWS-Fli1 protein inhibitors
TargetsEWS-Fli1 protein
Therapy Area/IndicationsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGradalis IncStrike Bio
China Registration ClassN/A

Develop Information

Active CompaniesStrike BioGradalis Inc
Inactive CompaniesN/A
Active IndicationsSarcoma, Ewing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A